Navigation Links
Hisamitsu Pharmaceutical Announces Two New FDA Approved Over-The-Counter Pain Relief Patches
Date:5/24/2010

TORRANCE, Calif., May 24 /PRNewswire/ -- Hisamitsu, a world leader in the manufacture of external pain relieving drugs, announced the release of two products for the American market—SALONPAS® PAIN RELIEF PATCH and ARTHRITIS PAIN.

(Photo: http://www.newscom.com/cgi-bin/prnh/20100524/LA09424)

Both SALONPAS® PAIN RELIEF PATCH and ARTHRITIS PAIN are the first and only FDA approved over-the-counter pain relief patches on the market today.  

SALONPAS® PAIN RELIEF PATCH/SALONPAS® ARTHRITIS PAIN patches are formulated for the temporary relief of the mild to moderate aches and pains of the muscles and joints associated with arthritis, sprains, strains, bruises and simple backaches experienced by patients age 18 or older.  The patches are ideally suited for seniors, workers, athletes and others. New SALONPAS® patches are effective for up to 12 hours, which contrasts with competing brands that are viable only up to 8 hours.

To introduce SALONPAS® patches, Hisamitsu will distribute over 2 million free samples.  Consumers may acquire them by visiting www.jointhepainfreemovement.com. People can also join SALONPAS® Facebook page and follow SALONPAS® on Twitter.

Joining SALONPAS® Facebook page also allows individuals to engage with the community of SALONPAS users and provide resources on pain relief and pain prevention at home, the office or on the athletic field.  

SALONPAS® patches are the smarter way to relieve pain because they are safe, long lasting. Because they are patches, they go directly to the source of pain. Originally developed in Japan, SALONPAS® analgesic patches have proven safe and effective in clinical trials.  Each patch contains 10% methyl salicylate and 3% I-menthol as the active pharmaceutical ingredients. They also offer an alternative for people who have a difficulty swallowing such as children or the elderly.  

SALONPAS® patches are available at major drug stores and big box outlets such as Rite Aid, CVS Pharmacy, Walgreens, Duane Reade, and others. Suggested retail price is $7.99.

SALONPAS® PAIN RELIEF PATCH and ARTHRITIS PAIN are the latest offering from Hisamitsu Pharmaceutical, a Japan based company founded in 1847. Hisamitsu introduced the original SALONPAS® patch in 1934 and their products are sold in approximately fifty countries around the world.

For more information visit www.jointhepainfreemovement.com.


'/>"/>
SOURCE Hisamitsu America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Yongxin Pharmaceuticals Reports First Quarter 2010 Financial Results
2. Ortho-McNeil Pharmaceutical, LLC Pleads Guilty to Illegal Promotion of Topamax and is Sentenced to Criminal Fine of $6.14 Million
3. Epix Pharmaceuticals, Inc. Announces a Change in the May 28, 2010 Auction Sale of Epix Imaging Agents to June 22, 2010
4. Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol
5. Isis Pharmaceuticals to Present at the 2010 Citi Investment Research Global Health Care Conference
6. Onyx Pharmaceuticals Announces Carfilzomib Data Presentations at 46th American Society of Clinical Oncology Annual Meeting
7. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
8. Renhuang Pharmaceuticals Exhibits All-Natural Products at the 107th China Import and Export Fair
9. DOAR Provides Trial Consulting Services in Victory for 5,600 Women in Gender Discrimination Class Action Trial Against Pharmaceutical Giant
10. WellPoint Is First Health Benefits Company to Release CER Guidelines for Use in Evaluating Pharmaceuticals
11. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , May 25,2016 FDA ... near-infrared Cellvizio platform for urological and surgical applications ... MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser ... milestone in the US with the 12 th ... Drug Administration (FDA). This new FDA clearance covers ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
(Date:5/25/2016)... -- According to market research "Global Insulin ... Forecast to 2022 - Industry Insights by Type (Insulin ... P&S Market Research, the global insulin delivery device market ... is expected to grow at a CAGR of 6.6% ... is expected to witness the fastest growth at a ...
Breaking Medicine Technology:
(Date:5/26/2016)... , ... May 26, 2016 , ... ... intellectual property (IP) to its specialty academic programs. , Answering to the increasing ... existing certificate programs in health law, and environmental and land use law. , ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James Maisel will ... Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public ... Retina Group of New York , is a Board Certified ophthalmologist who ...
(Date:5/26/2016)... ... 2016 , ... Leadership of Life Science Logistics (LSL), a ... earned its ISO 13485 certification, indicating the company’s quality control system for medical ... associated with ISO quality standard 13485. , BSI Group America, Inc., a ...
(Date:5/26/2016)... ... May 26, 2016 , ... Nike Yoga Camps ... from daily practices, arts & crafts, discussions, and games all geared towards enhancing ... Evans have combined backgrounds in kids’ yoga, collegiate sport yoga instruction, and global ...
Breaking Medicine News(10 mins):